Galleri Multi-Cancer Early Detection Test from Mito Health

Name: Galleri Multi-Cancer Early Detection Test
Brand: Mito Health
Price: 949 USD

Labbrary Test GradeUseful

Your Fit Score

050100?

Not calculated

Answer five questions to see how this panel matches your goals, budget, collection preferences, access, and support needs.

Calculate my fit

Labbrary's review, Fit Score, and basic comparison are free. The provider's panel, shipping, collection, clinician review, and other services are separate. About 2 minutes. No account required.

Analyzes cell-free DNA methylation patterns for a cancer-associated signal. A detected signal includes a predicted site of origin to guide diagnostic follow-up.

Current price: $949 from $958.50 with fees
Sample: Blood
Turnaround: Not confirmed
Access: Direct Lab, Lab Visit, Order Online

Evidence & Key Facts

Source collectedLast source check September 7, 2026

Evidence basis. This named result reflects the sources and verification evidence listed on this page as of the date shown.

Best for

Cancer Screening

Standout strength

Online ordering with collection at a participating laboratory.

Important watch-out

Quest Diagnostics: $949.00 nonmember or $798.12 member. Membership costs extra; lab choice and location determine the applicable price.

Galleri Multi-Cancer Early Detection Test from Mito Health

Labbrary Test GradeUseful

Your Fit Score

050100?

Not calculated

Answer five questions to see how this panel matches your goals, budget, collection preferences, access, and support needs.

Calculate my fit

Labbrary's review, Fit Score, and basic comparison are free. The provider's panel, shipping, collection, clinician review, and other services are separate. About 2 minutes. No account required.

Analyzes cell-free DNA methylation patterns for a cancer-associated signal. A detected signal includes a predicted site of origin to guide diagnostic follow-up.

Current price: $949 from $958.50 with fees
Sample: Blood
Turnaround: Not confirmed
Access: Direct Lab, Lab Visit, Order Online

Evidence & Key Facts

Source collectedLast source check September 7, 2026

Evidence basis. This named result reflects the sources and verification evidence listed on this page as of the date shown.

Best for

Cancer Screening

Standout strength

Online ordering with collection at a participating laboratory.

Important watch-out

Quest Diagnostics: $949.00 nonmember or $798.12 member. Membership costs extra; lab choice and location determine the applicable price.

Labbrary+

The Test Grade. The Reason Behind It.

Potentially useful for the right buyer, with meaningful evidence, coverage, transparency, access, cost, terms, or privacy tradeoffs to review.

A lower grade does not mean a panel is a bad personal fit. Your Fit Score can be higher when its purpose, price, sample, access, or support matches what you need.

Explore the Full Methodology

Labbrary Test GradeUseful

Next step

Check the panel or research the provider

Prices, availability, and ordering requirements can change. Confirm the current details before purchasing.

View Exact Panel on Provider Site View Mito Health profile

Scope, both directions

Inside the Panel. Beyond the Name.

Named measurements

Cell-free DNA methylation patterns for cancer signal detection

Measured categories and focus areas

Cancer Screening

Important limits and omissions

Exact order or draw fees and order-specific refund terms remain unconfirmed.
Exact analytical method, performing laboratory and offer-specific validation remain unconfirmed.
Exact specimen retention and sharing terms remain unconfirmed under the provider privacy policy.

The full breakdown

Eight Dimensions.
One Named Result.

Open any row for the reasoning and evidence behind the named result.

Mito states the sample is a standard blood draw collected in specialized cell-free DNA tubes and drawn at a CLIA and CAP-accredited lab, with Quest Diagnostics named in the availability table. The exact performing facility, the assay method, and analytical performance data are not published.

The test is described as a single blood draw screening for a shared cancer signal across many cancer types, including ones with no routine screening, for adults with elevated cancer risk typically age 50 and older. It is not recommended for people who are pregnant, 21 or younger, or undergoing active cancer treatment.

The page describes screening for a shared cancer signal across many cancer types but does not name how many cancer types are covered or list individual analytes, so the exact scope of the screen cannot be confirmed.

Results post to a dashboard after lab processing, a clinician reviews them before the analysis and action plan are finalized, and follow-up care is available. The exact report format and reference details are not published.

The offer publishes both prices, state availability, the lab system, HSA and FSA eligibility, and the ordering process. It does not publish the assay method, analytical performance data, or turnaround time for this specific test.

The test is available in 47 states and Washington, DC, excluding New Jersey, New York, and Rhode Island. Collection is a lab blood draw with online booking and walk-in availability, and Mito provides the laboratory order so no separate physician visit is needed.

The current offer lists $949.00 for non-members and $798.12 for members, with HSA and FSA cards accepted at checkout. Membership is $9 per month and optional, while order-specific refund terms are not published.

Mito publishes a privacy policy describing collection, disclosure to providers and service partners, retention of health data for up to seven years, and rights to access, export, and delete data. Test-specific specimen retention and sharing terms are not published.

What it asks of you

Sample and fulfillment journey

Order

Confirmed

Order this exact offer online. Mito arranges the laboratory order when one is required, so the buyer does not need a separate physician visit before purchase.

Panel-specific source · Source dated September 13, 2026

Collect

Confirmed

Attend a participating laboratory for the documented collection route.

Panel-specific source · Source dated September 13, 2026

Lab

Partially confirmed

The exact offer names Quest Diagnostics as the laboratory system, while the exact facility, assay method, and offer-specific performance remain unpublished.

Panel-specific source · Source dated September 13, 2026

Report

Confirmed

Results arrive in the Mito dashboard after laboratory processing and receive clinician review.

Panel-specific source · Source dated September 13, 2026

Under the hood

Follow the Evidence.

Every published claim should trace to a dated source. Missing evidence remains visible instead of being filled with assumptions.

Source 1Recorded for this record. Last source check September 7, 2026.View source

True total cost

The Price. Plus the Details.

Pricing for Galleri Multi-Cancer Early Detection Test
Item	Current disclosed price	Note
Panel	$949	Verify the checkout total, shipping, and collection fees before ordering.
Lab draw fee	+ $9.50 to $15	Per lab visit, added at checkout. One applies, depending on the lab you use: BioReference $9.50, Labcorp $11.50, Quest $15. Checked September 29, 2026. Source
Total at checkout	From $958.50	Listed price plus the required fees above, before tax and any optional services.
HSA/FSA payment	Conditional eligibility	HSA/FSA eligible. Confirm your plan requirements; eligibility does not guarantee reimbursement.
Optional services	At-home phlebotomist, $99	Only if you choose it. Not included in the total. Checked September 29, 2026. Source

Price status. This record shows disclosed pricing. Checkout costs can change and should be verified before purchase.

Your data

Your Data. Your Questions.

Privacy details are scored only when source documentation is available. Unconfirmed retention, deletion, research use, or marketing practices remain unconfirmed.

Reading the labels

What Has Been Checked?

Source collected

Evidence labels stay separate from the Test Grade. They show how much source support exists for the evaluation.

The balance

The Strengths. The Tradeoffs.

Strengths

Online ordering with collection at a participating laboratory.
Predicted cancer signal origin when a signal is detected.

Watch-outs

Quest Diagnostics: $949.00 nonmember or $798.12 member. Membership costs extra; lab choice and location determine the applicable price.
Not a cancer diagnosis; detected signals require diagnostic follow-up. Does not rule out all cancer or replace routine screening. Intended for adults at elevated risk, generally 50+; not recommended in pregnancy, under age 22, or active cancer treatment.
Personalized action plans require Mito membership. A separate one-to-one consultation costs $39 for members or $99 for nonmembers.
HSA/FSA eligible. Confirm your plan requirements; eligibility does not guarantee reimbursement.
Confirm any additional fees before purchase. Product-specific cancellation and refund terms have not been confirmed.
Unavailable in New Jersey, New York and Rhode Island.
A numeric turnaround estimate has not been confirmed; check timing before purchase.
No fasting is required. Collection uses specialized cell-free DNA tubes.

Take it with you

The Test Truth Card

The key facts from this review in one compact card.

Keep deciding

Galleri® Multi-Cancer Early Detection Test

Everlywell

Strong

Analyze cell-free DNA methylation patterns for cancer-associated signals using a blood sample collected at Quest. If a signal is detected, the report predicts its likely origin to help guide further evaluation.

Price: $949
Turnaround: 28 days

See Labbrary review View Exact Panel on Provider Site

Compare

Labbrary+

Marker by Labcorp™ Genetic Health Panel

Labcorp OnDemand

Strong

Examines measurements related to genetic risk and heart health so results can be reviewed in the appropriate health context.

Price: $499
Turnaround: 21 days

See Labbrary review View Exact Panel on Provider Site

Compare

Labbrary+

The Galleri Test

Galleri

Useful

Prescription blood test that looks for cancer-associated DNA methylation signals across more than 50 cancer types. It complements routine screening and predicts an origin when a signal is detected to guide diagnostic follow-up; a negative result does not rule out cancer.

Price: $799
Turnaround: 28 days

See Labbrary review View Official Panel Details

Compare

Labbrary+

Compare

Run a Pre-Buy Audit Explore All Tests Find My Best-Fit Tests

Verification History

September 7, 2026Recorded source date.Source collected

Affiliate disclosure. Some outbound links may earn Labbrary a commission. Affiliate relationships never influence a Test Grade.

Galleri Multi-Cancer Early Detection Test from Mito Health

The Test Grade. The Reason Behind It.

Check the panel or research the provider